12:00 AM
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Other News

BioDelivery, MonoSol Rx neurology, drug delivery news

The U.S. Patent and Trademark Office resolved two reexaminations of MonoSol's U.S. Patent Nos. 7,425,292 and 7,357,891, covering its PharmFilm technology for preparing drug-containing films. In February and March, the PTO respectively granted reexamination and rejected all claims in a non-final action for both patents. MonoSol said that in the reexamination certificates, the PTO canceled no claims and noted 33 new claims for the '292 patent and replaced the original...

Read the full 329 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >